Skip to content
May 23, 2022
  • Healthinnovations Twitter
  • Michelle Petersen Twitter
  • Michelle Petersen Linkedin
  • Healthinnovations facebook
  • Neuroinnovations facebook
  • Funkachellic Instagram
  • Healthinnovations insta
  • Healthinnovations Pinterest
  • Healthinnovations Tumblr
Healthinnovations- Latest Innovative Health & Medical News

Healthinnovations- Latest Innovative Health & Medical News

Primary Menu
  • About
  • Latest
  • Trending
  • SECTIONS
    • Artificial Intelligence
    • bio-computing
    • brain-computer interfaces
    • cancer
    • cardiology
    • immunology
    • infertility
    • diabetes
    • genetics
    • microbiota
    • nanorobotics
    • nanotechnology
    • neuroinnovations
    • Synthetic BiologyRead the latest breakthroughs and discoveries in synbio research and treatments.
  • Contact us
  • Home
  • 2014
  • September
  • 11
  • Blocking one receptor on cells could halt rheumatoid arthritis.
  • arthritis
  • autoimmune disease
  • healthinnovations
  • immunology
  • inflammation
  • osteoclasts
  • rheumatoid arthritis
  • TLR5
  • toll-like receptor 5

Blocking one receptor on cells could halt rheumatoid arthritis.

Healthinnovations September 11, 2014 3 min read

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)

Researchers at the University of Illinois have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis, and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.  Their findings point to a new therapeutic target to interrupt the vicious cycle of inflammation and bone erosion in rheumatoid arthritis.

Rheumatoid arthritis is a progressive autoimmune inflammatory disease of the joints. Swelling and pain, caused by certain cells flooding into the joints, is a hallmark of the disease, along with progressive bone loss. The UIC researchers have shown that the process begins with the triggering of a single receptor on a group of white blood cells.

TLR5 does it all.  TLR5, or toll-like receptor 5, is found on myeloid, or marrow-derived, cells that migrate from the blood into affected joints.  The team found that the receptor is much more abundant on myeloid cells found in the fluid of joints in patients with rheumatoid arthritis as compared to samples from healthy subjects.

In previous studies the team found that activation of TLR5 causes abnormal blood vessel formation in the joints of rheumatoid arthritis patients. In the new study they found that the receptor also up-regulates a potent inflammatory molecule called TNF-alpha, which recruits even more myeloid cells into the joint, where they are transformed into bone-degrading cells called osteoclasts.

In a series of experiments, the researchers uncovered multiple pathological processes driven by the activation of the receptor.  When the researchers placed TLR5-expressing myeloid cells next to joint fluid from rheumatoid arthritis patients, the cells migrated into the fluid. But if the receptor was blocked by an antibody, cell migration towards the fluid was significantly reduced.

Something in the joint fluid attracts cells with TLR5, perhaps TLR5’s binding protein, which is most likely present in joints affected by rheumatoid arthritis.

The researchers also found that levels of TNF-alpha increased in joint fluid from patients with rheumatoid arthritis when myeloid cells with activated TLR5 were present. Patients with rheumatoid arthritis who take anti-TNF-alpha drugs have lower levels of TLR5 on their myeloid cells, suggesting that a positive feedback loop exists between TLR5 and TNF-alpha, so that an elevation in one causes an increase in the other.

Not only do TLR5 and TNF-alpha regulate each other, but they work synergistically to attract more myeloid cells into the joint, where they are transformed into bone-eroding cells.

In a mouse model of rheumatoid arthritis, experimental mice given an antibody that blocked the TLR5 receptor had markedly reduced joint swelling and bone erosion compared to controls. The TLR5 antibody treatment may reduce swelling by lowering the number of myeloid cells migrating into the joints to become osteoclasts, the researchers said.

Based on her studies in mice, the researchers summise a drug that prevents TLR5 activation could slow or prevent the inflammation and bone erosion of later-stage rheumatoid arthritis in patients.

When TLR5 is activated, it initiates a vicious feedback loop that results in a worsening of both the inflammatory and erosive features of rheumatoid arthritis.  The receptor is a major driver of inflammation and bone degradation. Blocking this receptor could have significant therapeutic value in interrupting joint swelling and bone loss in patients with rheumatoid arthritis.

Source:  University of Illinois at Chicago College of Medicine

 

 Toll-Like Receptors Pathways.  TLRs (Toll-like receptors) are transmembrane proteins expressed by cells of the innate immune system, which recognize invading microbes and activate signaling pathways that launch immune and inflammatory responses to destroy the invaders.  Multiple references.  © QIAGEN 2013–14. All rights reserved.
Toll-Like Receptors Pathways. TLRs (Toll-like receptors) are transmembrane proteins expressed by cells of the innate immune system, which recognize invading microbes and activate signaling pathways that launch immune and inflammatory responses to destroy the invaders. Multiple references. © QIAGEN 2013–14. All rights reserved.

 

Related

Tags: arthritis autoimmune disease healthinnovations immunology inflammation osteoclasts rheumatoid arthritis TLR5 toll-like receptor 5

Continue Reading

Previous FDA approves weight-management drug Contrave.
Next Chemists discover new mode of detection in nose for common class of odours.

Leave a Reply Cancel reply

Get more health innovations like this...

Join the Healthinnovations newsletter for news on incredible clinical trials and exclusive scoops. More than 35,000 subscribers can't be wrong.

Featured in:

artwork for zme science Healthinnovations was invited to take part in the now legendary BBC World Service panel on the Danish Fat Tax, which is currently being rebroadcast by the BBC. michigan state university has featured healthinnovations on their site Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level’ starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. The renowned Top 10 Healthinnovations series is featured on the Texas A&M University site. Stephen Maren, Texas A&M University Distinguished Professor in the Department of Psychological & Brain Sciences, had research that was named one of Health Innovations’ renowned Top 10 Healthinnovations of 2019. https://liberalarts.tamu.edu/blog/2020/01/07/ptsd-research-named-among-top-10-health-innovations/ Michelle Petersen Verified Muck Rack portfolio in journalism.

All archived posts

You may have missed

healthinnovations covid vaccine artwork omnicron
3 min read
  • healthinnovations
  • immunology
  • opensource

New study tells you which vaccines can protect you against Omicron.

January 6, 2022 Healthinnovations 1
the top 10 healthinnovations of 2021 art work
1 min read
  • healthinnovations
  • immunology
  • infertility
  • microbiota
  • nanorobotics
  • nanotechnology
  • neuroinnovations
  • synthetic biology

The Top 10 Healthinnovations of 2021 – Slideshow.

January 4, 2022 Healthinnovations
Scientists have developed a novel therapy that repairs spinal cord injury in mice, enabling them to walk again within weeks of treatment - the new class of material works by signaling to the spinal cord to repair damaged nerves.
3 min read
  • healthinnovations
  • nanotechnology
  • neuroinnovations
  • synthetic biology

A new type of drug reverses spinal paralysis.

December 7, 2021 Healthinnovations 3
Researchers have successfully attached a pig kidney to a human recipient where it functioned for three days – in a massive leap toward an alternative supply of organs for those desperately awaiting transplants.
3 min read
  • healthinnovations
  • immunnology

Pig kidney successfully attached to human

November 30, 2021 Healthinnovations
  • About
  • Latest
  • Trending
  • SECTIONS
    • Artificial Intelligence
    • bio-computing
    • brain-computer interfaces
    • cancer
    • cardiology
    • immunology
    • infertility
    • diabetes
    • genetics
    • microbiota
    • nanorobotics
    • nanotechnology
    • neuroinnovations
    • Synthetic Biology
  • Contact us
  • RSS: All Posts
  • RSS: Cancer Posts
  • RSS: Genetics Posts
  • RSS: Immunology Posts
  • RSS: Nanotech Posts
  • RSS: Neuroinnovations Posts
  • RSS: Synbio Posts
  • Terms of Use
  • Privacy Policy
  • Healthinnovations Twitter
  • Michelle Petersen Twitter
  • Michelle Petersen Linkedin
  • Healthinnovations facebook
  • Neuroinnovations facebook
  • Funkachellic Instagram
  • Healthinnovations insta
  • Healthinnovations Pinterest
  • Healthinnovations Tumblr
Copyright Healthinnovations © All rights reserved. EnterNews by AF themes.
It's your choice
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. You can find out more in our privacy policy and cookie policy, and manage the choices available to you at any time by going to ‘Privacy settings’ at the bottom of any page.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
 

Loading Comments...